Organoids Market to Expand with Significant CAGR During 2019-2029 - PowerPoint PPT Presentation

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: Organoids Market to Expand with Significant CAGR During 2019-2029

Organoids Market to Partake Significant
Development During 2019-2029
  • March 2020

Report Id REP-GB-8106 Published On
September-2019 Category Healthcare,
Pharmaceuticals Medical Devices
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
Organoids Market Analysis
  • Organoids Market to Partake Significant
    Development During 2019-2029
  • Traditional methods of drug discovery are
    inadequate and less relevant to the pace of the
    growing life science research and development.
    Organoids are, therefore, expected to generate a
    major revenue share in the market for drug
    discovery applications in the near future.
    Increasing failure rate in human preclinical
    trails is luring academicians and researchers to
    explore more possible organoid models for
    toxicology research and potential regenerative
    mediation research, thereby propelling the demand
    for organoids. Use of animals for research and
    testing has led to the creation of numerous
    initiatives and campaigns regarding the debatable
    issue. According to Humane Society International,
    more than 115 million animals are used for
    research in laboratories worldwide every year.
    Organoids are anticipated to substitute animals
    for testing in laboratories. Organoids are
    proving to be an appropriate alternate for animal
    testing models. The organoids market is growing
    with increasing support and initiatives to limit
    the use of animals for testing through regulatory
    guidelines. Thus, the rising focus on
    substituting animal model for research, along
    with development of commercially available
    organoids, is likely to boost the growth of the
    global organoids market.
  • According to the latest report published by FMI,
    the global organoids market is expected to reach
    US 134 Mn by the forecast year 2029. The
    report further projects that the organoids market
    will grow at a CAGR of 15 during the forecast
    period 2019-2029.
  • Organoids and 3D cell cultures are growing
    rapidly in popularity, replacing 2D cell culture
    in traditional methods of research in human
    developmental biology. With an alarming rise in
    the prevalence of cancer, the need for novel
    drugs has grown significantly, and this is
    expanding the scope of applications for organoids
    in oncology research. In the past few years, a
    mounting number of pharma companies have been
    focusing on introducing personalised oncology
    drugs, and leading stakeholders are joining the
    bandwagon by adopting strategies of creating
    cancer organoids for individual patients, in
    order to leverage the new avenues of growth in
    oncology research.

Organoids Market Analysis
  • Organoids Market Dynamics
  • Over the last few years, organoids have gained
    significant popularity among the research groups
    working on advanced 3D cell culture. The primary
    driver for the organoids market is considered to
    be the attainment of greater degree of
    resemblance to the cell specific structure of the
    specific organ, in vivo environmental conditions.
    Organoids are used for cell toxicity screening,
    cell-based assays, and organ specific cell
    functions. Cell cultures in 2D environment limit
    or restrict their ability to depict traits
    exhibited by in vivo systems, because of the
    morphological and locomotion limitations imposed
    by the 2D atmosphere. The ability of organoids to
    meticulously mimic the specific cells of the
    organs from which they are derived, leads to
    accurate models of tissues. This factor is
    considered to be a strong driver for the
    organoids market growth. Presently, advancements
    in 3D cell culture technology have developed a
    potential scope for development of cancer
    specific organoids with research of potential
    applications. This factor is expected to play an
    instrumental role in driving the growth of the
    organoids market.
  • Europe Takes the Centre Stage in the Organoids
  • Lack of skilled professionals engaged in research
    and developmental activities is expected to
    hamper the growth of the organoids market. A
    study presented by Tufts University in Boston,
    showed that it costs around US 2.6 million to
    develop a new drug and a standard prescription
    for the commercial market approval, due to high
    failure rates in human drug testing. Organoids
    offer viable model for the human disease models
    specific to organ tissue for drug screening in
    preclinical trials.

Organoids Market Analysis
  • Europe organoids markets are expected to witness
    significant growth, in the view of increasing
    research activities in organoids field and
    growing number of sponsor for the study in these
    regions, as well as growing trend in academic
    research to work with organoid models, to explore
    more viable applications. Additionally,
    increasing bio-banking activity in the region is
    anticipated to propel the organoid market growth.
     Furthermore, rising research and development in
    3D cell culture technology, prominent presence of
    manufacturers, and initiatives for replacing
    animal models in research studies with organoids
    are some of the factors propelling the growth of
    the organoid market. The Europe organoids market
    is estimated to create an estimated incremental
    opportunity worth approximately US 38 Mn between
    2019 and 2029.
  • Organoids Market Segmental Analysis
  • The global organoids market has been segmented by
    product type, application, end user, and region.
    Furthermore, the organoids market has been
    segmented by product type into Intestinal
    Organoid, Hepatic Organoid, Pancreatic Organoid,
    Colorectal Organoid, Neural Organoid and Others,
    which are used for the developing full organoid
    models for research. The application segment of
    the organoids market is segmented into
    Bio-banking, Biomedical Research and Drug
    Discovery, Regenerative Medicine, Cancer
    Research, Therapeutic Tools and Others.
    Bio-banking segment is expected to hold a large
    share during the forecast period. As per end
    user, the organoids market is segmented into
    Biopharmaceutical Companies, Contract Research
    Organizations and Academics and Research

Organoids Market Analysis
  • Organoids Market Companies
  • The report tracks some of the key companies
    operating in the Organoids market, such as
    Hubrecht Organoid Technology (HUB), STEMCELL
    Technologies Inc., Cellesce Ltd., DefiniGEN, Qgel
    and OcellO B.V.
  • Sourcehttp//
  • More from FMIs Healthcare, Pharmaceuticals and
    Medical devices Market Intelligence
  • Narcolepsy Treatment Market
  • Respiratory Devices Market
  • About Us
  • Future Market Insights (FMI) is a leading market
    intelligence and consulting firm. We deliver
    syndicated research reports, custom research
    reports and consulting services which are
    personalized in nature. FMI delivers a complete
    packaged solution, which combines current market
    intelligence, statistical anecdotes, technology
    inputs, valuable growth insights and an aerial
    view of the competitive framework and future
    market trends.

Organoids Market Analysis
  • Contact Us
  • Mr. Abhishek Budholiya616 Corporate Way, Suite
    2-9018,Valley Cottage, NY 10989,United
    StatesT 1-347-918-3531F 1-845-579-5705T
    (UK) 44 (0) 20 7692 8790Sales sales_at_futuremar
    ketinsights.comPress Office Press_at_futuremarketin
    sights.comFuture Market Insights

To know more about us, please visit our website For sales queries
or new topics email us on sales_at_futuremarketinsi For media queries, contact the press
office at For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)